[Therapeutic effects of furazabol, (17-beta-hydroxy-17-alpha-methyl-5-alpha-androstane [2, 3-c] furazan, on experimental atherosclerosis in rabbits].
D045930:Anabolic Agents / Q000627:therapeutic use*; D000731:Androstanes / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D002784:Cholesterol / Q000097:blood; D004041:Dietary Fats; D005663:Furans / Q000494:pharmacology; D008055:Lipids / Q000097:blood; D008297:Male; D011817:Rabbits; D013261:Sterols / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood
D045930:Anabolic Agents; D000731:Androstanes; D004041:Dietary Fats; D005663:Furans; D008055:Lipids; D013261:Sterols; D014280:Triglycerides; D002784:Cholesterol